Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats (Q42701879)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2015

Language	Label	Description	Also known as
English	Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats	scientific article published on May 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

0 references

author name string

Erquan Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Junko Maruyama

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Ayumu Yokochi

3

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Yoshihide Mitani

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Hirofumi Sawada

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Masakatsu Nishikawa

6

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Ning Ma

7

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Kazuo Maruyama

8

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

publication date

1 May 2015

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Journal of Anesthesia

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

715-723

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Molecular pathogenesis of pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action?

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Increased plasma serotonin in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Evidence for a control of plasma serotonin levels by 5-hydroxytryptamine(2B) receptors in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935.

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Changes in plasma serotonin concentration and acceleration plethysmograms in patients with Raynaud's phenomenon after long-term treatment with a 5-HT2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A randomized, double-blind, aspirin-controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Sarpogrelate, a specific 5HT2-receptor antagonist, improves the coronary microcirculation in coronary artery disease

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Effect of all-trans-retinoic acid on the development of chronic hypoxia-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Atrial natriuretic peptide gene transfection with a novel envelope vector system ameliorates pulmonary hypertension in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Acute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP-13 expression in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Changes in pulmonary blood flow affect vascular response to chronic hypoxia in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Effects of sarpogrelate, a novel 5-HT2 antagonist, on 5-HT-induced endothelium-dependent relaxations in porcine coronary artery

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Binding and functional affinity of sarpogrelate, its metabolite m-1 and ketanserin for human recombinant alpha-1-adrenoceptor subtypes

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Effect of a serotonin receptor antagonist on interleukin-6-induced pulmonary hypertension in rats

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00540-015-2015-Y

21 January 2018

The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25931318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/25931318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25931318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of monocrotaline-induced pulmonary hypertension is attenuated by a serotonin receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/25931318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vasodilatory effects of ketamine on pulmonary arteries in rats with chronic hypoxic pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25931318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features

1 reference

https://pubmed.ncbi.nlm.nih.gov/25931318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/25931318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25931318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppressive effect of sarpogrelate hydrochloride on respiratory failure and right ventricular failure with pulmonary hypertension in patients with systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25931318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/25931318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous low-dose NO inhalation does not prevent monocrotaline-induced pulmonary hypertension in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/25931318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/25931318

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00540-015-2015-Y

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

release_konsswkegbbjjhqngf2iilnzua

1 reference

https://api.fatcat.wiki/v0/release/konsswkegbbjjhqngf2iilnzua

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42701879&oldid=2146290800"